E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/24/2006 in the Prospect News Biotech Daily.

New Issue: AngioDynamics raises $57.8 million in follow-on of 2.4 million shares at $24.07 each

By Ronda Fears

Memphis, May 24 - AngioDynamics, Inc. raised $57.77 million from a follow-on offering of 2.4 million shares at $24.07 each, pat with Tuesday's close, via bookrunner RBC Capital Markets.

Queensbury, N.Y.-based AngioDynamics, maker of therapeutic and diagnostic medical devices to treat peripheral vascular disease and other non-coronary diseases, said proceeds would be used to support its growth strategy, including possible acquisitions, working capital and other general corporate purposes.

Issuer:AngioDynamics, Inc.
Issue:Follow-on stock offering
Gross proceeds:$57.77 million
Net proceeds:$54.31 million
Shares:2.4 million
Greenshoe:360,000
Price:$24.07 per share
Bookrunner:RBC Capital Markets
Co-managers:Canaccord Adams, First Albany Capital, KeyBanc Capital Markets
Pricing date:May 23
Settlement date:May 30
Stock symbol:Nasdaq: ANGO
Stock price:$24.07 on May 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.